2-Bromo-4-fluoro-6-isopropylaniline

Catalog No.: 
ACTIFE364
CAS No.: 
2260959-41-7
Molecular Formula: 
C9H11BrFN
Molecular Weight: 
232.10
2-Bromo-4-fluoro-6-isopropylaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$62.00In stockInquiry
100mg95%$106.00In stockInquiry
250mg95%$201.00In stockInquiry
1g95%$540.00In stockInquiry
5g95%$2565.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-4-fluoro-6-isopropylaniline
IUPAC Name2-bromo-4-fluoro-6-isopropylaniline
MDL No.MFCD32706540
Molecular FormulaC9H11BrFN
Molecular Weight232.10
SMILESNC1=C(C(C)C)C=C(F)C=C1Br
InChI KeyZLLFSDAAWDEART-UHFFFAOYSA-N
SynonymBenzenamine, 2-bromo-4-fluoro-6-(1-methylethyl)-;2-bromo-4-fluoro-6-isopropylaniline;2-Bromo-4-fluoro-6-(1-methylethyl)benzenamine;2-bromo-4-fluoro-6-(propan-2-yl)aniline
CAS No.2260959-41-7
PubChem CID137380134

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTIFE364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTIFE364 route product structure diagram
    ACTIFE3642260959-41-7In Stock
Inquiry

2. ACTIFE364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTIFE364 route product structure diagram
    ACTIFE3642260959-41-7In Stock
Inquiry

3. ACTIFE364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTIFE364 route product structure diagram
    ACTIFE3642260959-41-7In Stock
Inquiry

Comments (0)